Amphastar Pharmaceuticals (AMPH)
NASDAQ:AMPH
Holding AMPH?
Track your performance easily

Amphastar Pharmaceuticals (AMPH) Financial Statements

368 Followers

Amphastar Pharmaceuticals Financial Overview

Amphastar Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $3.138; its P/E ratio is 14.82; Amphastar Pharmaceuticals is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $1.01. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 182.39M$ 171.84M$ 178.10M$ 180.56M$ 72.74M
Gross Profit$ 95.17M$ 90.10M$ 96.14M$ 108.40M$ 72.74M
EBIT$ 50.24M$ 55.91M$ 50.80M$ 77.34M$ 36.11M
EBITDA$ 66.82M$ 72.00M$ 64.59M$ 96.15M$ 46.38M
Net Income Common Stockholders$ 37.95M$ 43.18M$ 36.17M$ 49.22M$ 26.12M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 217.78M$ 289.56M$ 256.81M$ 299.88M$ 165.84M
Total Assets$ 1.49B$ 1.57B$ 1.51B$ 1.54B$ 1.38B
Total Debt$ 620.58M$ 627.12M$ 623.64M$ 672.56M$ 528.74M
Net Debt$ 402.81M$ 337.56M$ 366.84M$ 372.68M$ 362.90M
Total Liabilities$ 778.18M$ 901.96M$ 873.49M$ 949.49M$ 789.03M
Stockholders Equity$ 713.35M$ 672.36M$ 639.42M$ 595.14M$ 589.24M
Cash Flow-
Free Cash Flow$ 63.06M$ 46.50M$ 14.42M$ 54.14M$ 45.87M
Operating Cash Flow$ 69.11M$ 55.29M$ 23.86M$ 64.33M$ 54.92M
Investing Cash Flow$ -69.90M$ 15.24M$ -103.05M$ -31.15M$ -508.58M
Financing Cash Flow$ -10.72M$ -13.58M$ -47.08M$ 86.61M$ 428.11M
Currency in USD

Amphastar Pharmaceuticals Earnings and Revenue History

Amphastar Pharmaceuticals Debt to Assets

Amphastar Pharmaceuticals Cash Flow

Amphastar Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis